|Bid||159.670 x 1200|
|Ask||159.780 x 100|
|Day's Range||159.483 - 159.769|
|52 Week Range||126.420 - 160.200|
|PE Ratio (TTM)||9.29|
|Expense Ratio (net)||0.25%|
Small-capitalization stock investors were defensive going into the 2017, but they have quickly changed their tune, turning to more growth-weighted smaller company picks. Investors can also gain diversified ...
Eli Lilly’s (LLY) Captisol-enabled drug Prexasertib is currently being evaluated in multiple oncology indications such as head and neck cancer, small-cell lung cancer (or SCLC), and advanced metastatic ...
Ligand Pharmaceuticals (LGND) expects its licensees to invest ~$2.0 billion for advancing more than 155 partnered research and development programs in 2017.